Key Market Indicators
The Dutch insulin market is expected to reach $245.2 million by 2026, growing at a compound annual growth rate (CAGR) of 2% from 2021 to 2026. Since 1997, Dutch demand has grown at an average of 4.6% a year. In 2018, Dutch insulin exports totalled $778,580, a 21.2% drop from the $988,500 exported in 2017. Since 1997, Dutch supply has fallen by an average of 39.6% annually. In 2018, the country was ranked 34th in the world, behind Austria, France, Italy and China.
